Therapeutic Nanoparticles: Advantages and Toxicity
Open Access
- 30 May 2022
- journal article
- Published by Lattice Science Publication (LSP) in Indian Journal of Environment Engineering
- Vol. 1 (3), 19-37
- https://doi.org/10.54105/ijee.c1828.051322
Abstract
The present review focused on various advantages and hazardous aspects of therapeutically used nanoparticles. Therapeutic applications of nanoparticles have been covered in cancer diagnosing and therapy, surgery, bio-detection of disease markers, molecular imaging, implant application, tissue engineering, and devices for gene, drug, radionuclide, and protein delivery. Many therapeutic nanotechnology applications are still in their beginning stages. However, promising applications are being developed especially in the field of cancer therapy. Nanoparticles are proficient as carriers for chemo-therapeutic drugs and enhance their therapeutic index. These NPs act as therapeutic agents in gene and photothermal therapy. Furthermore, they function as molecular imaging agents to distinguish target cells and monitor cancer progression. Finally, the generations of toxic biological responses of these nanoparticles are mentioned based on detailed explanations of NPs toxicity assessment. Evaluation of potential toxicity of NPs are mainly comprises of its physicochemical properties, inclusive particle characterization (such as size, shape, specific surface area, agglomeration, solubility, element impurity etc.), function of cellular and non-cellular in vitro toxicity assessment and animal supported toxicological measures.Keywords
This publication has 100 references indexed in Scilit:
- Photoswitchable Nanoparticles for Triggered Tissue Penetration and Drug DeliveryJournal of the American Chemical Society, 2012
- Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigensVaccine, 2012
- cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imagingBiomaterials, 2011
- Tracking and quantitation of fluorescent HIV during cell-to-cell transmissionMethods, 2011
- Inorganic Nanoparticles in Cancer TherapyPharmaceutical Research, 2010
- Porous Hollow Fe3O4 Nanoparticles for Targeted Delivery and Controlled Release of CisplatinJournal of the American Chemical Society, 2009
- Quantum dots and nanoparticles for photodynamic and radiation therapies of cancerAdvanced Drug Delivery Reviews, 2008
- Bioconjugated quantum dots for in vivo molecular and cellular imagingAdvanced Drug Delivery Reviews, 2008
- Factors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesMolecular Pharmaceutics, 2008
- Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200)Gynecologic Oncology, 2008